©The Author(s) 2026.
World J Gastrointest Surg. Jan 27, 2026; 18(1): 115285
Published online Jan 27, 2026. doi: 10.4240/wjgs.v18.i1.115285
Published online Jan 27, 2026. doi: 10.4240/wjgs.v18.i1.115285
Table 12 Summary of meta-analysis and sensitivity analysis
| Variable | Number of studies | Global effect size (%) | Heterogeneity (I2) |
| Overall diagnostic performance of the staging laparoscopy | 18 | 22 (95%CI: 17-27) | 88.3% |
| Positive peritoneal malignancy | 15 | 19 (95%CI: 14-24) | 83.6% |
| Positive peritoneal carcinomatosis | 18 | 13 (95%CI: 10-17) | 82.8% |
| Hepatic metastatic disease | 6 | 9 (95%CI: 4-14) | 81.7% |
| Diagnostic performance - Siewert I | 4 | 18 (95%CI: 8-28) | 93.7% |
| Diagnostic performance - Siewert II | 3 | 13 (95%CI: 8-18) | 0% |
| Positive peritoneal malignancy - Siewert I | 3 | 7 (95%CI: 1-12) | 84.4% |
| Positive peritoneal malignancy - Siewert II | 2 | 11 (95%CI: 5-18) | 0% |
- Citation: de la Plaza Llamas R, Ribera Díaz D, Betancor Díaz P, Díaz Candelas DA, Latorre-Fragua RA, Gorini L, Arellano González R, Gemio del Rey IA. Staging laparoscopy in esophagogastric junction cancer: Systematic review and meta-analysis. World J Gastrointest Surg 2026; 18(1): 115285
- URL: https://www.wjgnet.com/1948-9366/full/v18/i1/115285.htm
- DOI: https://dx.doi.org/10.4240/wjgs.v18.i1.115285